REQUEST A DEMO
Total
USD $0.00
Search more companies

Genus Pharma S.R.O. (Slovakia)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Genus Pharma S.R.O. Profile Updated: October 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Genus Pharma S.R.O. is an enterprise located in Slovakia, with the main office in Zarnovica. The company operates in the Administrative Management and General Management Consulting Services sector. It was established on September 07, 2012. In its most recent financial highlights, the company reported a net sales revenue increase of 23.34% in 2023. There was a total growth of 148.49% in Genus Pharma S.R.O.’s total assets over the same period. The net profit margin of Genus Pharma S.R.O. decreased by 1.78% in 2023.

Headquarters
Bystricka, 901
Zarnovica; Banskobystricky; Postal Code: 96681

Contact Details: Purchase the Genus Pharma S.R.O. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Genus Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Genus Pharma S.R.O. report to view the information.
Incorporation Date:
September 07, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Genus Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
23.34%
Total operating revenue
-5.45%
Operating profit (EBIT)
3.06%
EBITDA
-16.13%
Net Profit (Loss) for the Period
-15.77%
Total assets
148.49%
Total equity
72.19%
Operating Profit Margin (ROS)
-1.41%
Net Profit Margin
-1.78%
Return on Equity (ROE)
-43.78%
Debt to Equity Ratio
-3.19%
Quick Ratio
0.89%
Cash Ratio
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?